Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masaoki Ito

Showing results (21-30 of 61) with videos related to

Pageof 7
Sort By:
Biomedicines|July 27, 2024
Potential Utility of a 4th-Generation EGFR-TKI and Exploration of Resistance Mechanisms-An In Vitro StudyShota Fukuda, Kenichi Suda, Akira Hamada, et al.
Annals of Surgical Oncology|November 17, 2019
Intense Expression of EGFR L858R Characterizes the Micropapillary Component and L858R Is Associated with the Risk of Recurrence in pN0M0 Lung Adenocarcinoma with the Micropapillary ComponentNaoto Kishi, Masaoki Ito, Yoshihiro Miyata, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|February 11, 2017
Second predominant subtype predicts outcomes of intermediate-malignant invasive lung adenocarcinoma†Masaoki Ito, Yoshihiro Miyata, Tomoharu Yoshiya, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|October 31, 2022
Impact of the amount of preoperative erector spinae muscle in stage I non-small-cell lung cancerDaisuke Ueda, Yasuhiro Tsutani, Atsushi Kamigaichi, et al.
Lung Cancer (Amsterdam, Netherlands)|July 1, 2014
Prediction for prognosis of resected pT1a-1bN0M0 adenocarcinoma based on tumor size and histological status: relationship of TNM and IASLC/ATS/ERS classificationsMasaoki Ito, Yoshihiro Miyata, Kei Kushitani, et al.
Thoracic Cancer|September 20, 2024
Clinical factors associated with high PD-L1 expression in patients with early-stage non-small cell lung cancerShuta Ohara, Kenichi Suda, Akira Hamada, et al.
British Journal of Cancer|August 10, 2021
Coregulation of pathways in lung cancer patients with EGFR mutation: therapeutic opportunitiesRafael Rosell, Andrés Felipe Cardona, Oscar Arrieta, et al.
Lung Cancer (Amsterdam, Netherlands)|January 31, 2012
Prognostic impact of the primary tumor location based on the hilar structures in non-small cell lung cancer with mediastinal lymph node metastasisMasaoki Ito, Yoshinori Yamashita, Yoshihiro Miyata, et al.
Thoracic Cancer|October 10, 2018
Increased risk of recurrence in resected EGFR-positive pN0M0 invasive lung adenocarcinomaMasaoki Ito, Yoshihiro Miyata, Kei Kushitani, et al.
Journal of Cancer Research and Clinical Oncology|July 4, 2021
Sensitivity and optimal clinicopathological features for mutation-targeted liquid biopsy in pN0M0 EGFR-mutant lung adenocarcinomaMasaoki Ito, Yoshihiro Miyata, Shoko Hirano, et al.
Pageof 7

Showing results (21-30 of 61) with videos related to

Sort By:
Pageof 7
Biomedicines|July 27, 2024
Potential Utility of a 4th-Generation EGFR-TKI and Exploration of Resistance Mechanisms-An In Vitro StudyShota Fukuda, Kenichi Suda, Akira Hamada, et al.
Annals of Surgical Oncology|November 17, 2019
Intense Expression of EGFR L858R Characterizes the Micropapillary Component and L858R Is Associated with the Risk of Recurrence in pN0M0 Lung Adenocarcinoma with the Micropapillary ComponentNaoto Kishi, Masaoki Ito, Yoshihiro Miyata, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|February 11, 2017
Second predominant subtype predicts outcomes of intermediate-malignant invasive lung adenocarcinoma†Masaoki Ito, Yoshihiro Miyata, Tomoharu Yoshiya, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|October 31, 2022
Impact of the amount of preoperative erector spinae muscle in stage I non-small-cell lung cancerDaisuke Ueda, Yasuhiro Tsutani, Atsushi Kamigaichi, et al.
Lung Cancer (Amsterdam, Netherlands)|July 1, 2014
Prediction for prognosis of resected pT1a-1bN0M0 adenocarcinoma based on tumor size and histological status: relationship of TNM and IASLC/ATS/ERS classificationsMasaoki Ito, Yoshihiro Miyata, Kei Kushitani, et al.
Thoracic Cancer|September 20, 2024
Clinical factors associated with high PD-L1 expression in patients with early-stage non-small cell lung cancerShuta Ohara, Kenichi Suda, Akira Hamada, et al.
British Journal of Cancer|August 10, 2021
Coregulation of pathways in lung cancer patients with EGFR mutation: therapeutic opportunitiesRafael Rosell, Andrés Felipe Cardona, Oscar Arrieta, et al.
Lung Cancer (Amsterdam, Netherlands)|January 31, 2012
Prognostic impact of the primary tumor location based on the hilar structures in non-small cell lung cancer with mediastinal lymph node metastasisMasaoki Ito, Yoshinori Yamashita, Yoshihiro Miyata, et al.
Thoracic Cancer|October 10, 2018
Increased risk of recurrence in resected EGFR-positive pN0M0 invasive lung adenocarcinomaMasaoki Ito, Yoshihiro Miyata, Kei Kushitani, et al.
Journal of Cancer Research and Clinical Oncology|July 4, 2021
Sensitivity and optimal clinicopathological features for mutation-targeted liquid biopsy in pN0M0 EGFR-mutant lung adenocarcinomaMasaoki Ito, Yoshihiro Miyata, Shoko Hirano, et al.
Pageof 7